Literature DB >> 11831401

Usefulness of indium-111-oxine-labeled leukocyte scintigraphy in diagnosis of inflammation associated with chronic aortic dissection.

K Takahashi1, M Ohyanagi, H Naruse, M Masai, T Iwasaki, M Fukuchi, T Miyamoto.   

Abstract

BACKGROUND: Patients with chronic aortic dissection require monitoring for indications of disease progression. In present study, inflammation adjacent to associated aortic wall was evaluated by indium-111-oxine-labeled leukocyte scintigraphy, scince inflammation of the blood vessel wall often associates with progression of chronic aortic dissection. METHODS AND
RESULTS: Fifteen patients with aortic dissection underwent indium-111-oxine-labeled leukocyte scintigraphy. Seven showed positive images at sites corresponding to the actual sites of the dissociated aorta. Four patients with positive images underwent surgery. Histologic examination revealed inflammatory and necrotic changes of the aortic wall. During a mean follow-up period of 2.3 years, progression of aortic dissection was observed in two of the seven patients with positive intimal imaging.
CONCLUSION: Indium-111-oxine-labeled leukocyte scintigraphy may be a useful noninvasive technique to assess the persistent inflammation in patients with chronic aortic dissection.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11831401     DOI: 10.1007/bf02988507

Source DB:  PubMed          Journal:  Ann Nucl Med        ISSN: 0914-7187            Impact factor:   2.668


  2 in total

1.  Guidelines for the labelling of leucocytes with (111)In-oxine. Inflammation/Infection Taskgroup of the European Association of Nuclear Medicine.

Authors:  Manel Roca; Erik F J de Vries; Francois Jamar; Ora Israel; Alberto Signore
Journal:  Eur J Nucl Med Mol Imaging       Date:  2010-04       Impact factor: 9.236

2.  Contrast-enhanced magnetic resonance imaging to detect chronic aortic dissection complicated by acute aortitis.

Authors:  Kotaro Ouchi; Toru Sakuma; Kunihiko Fukuda; Michio Yoshitake
Journal:  Radiol Case Rep       Date:  2017-04-29
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.